Literature DB >> 26016703

Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases.

Hong Zhu1, Dandan Dong1, Fanghua Li1, Dandan Liu1, Lei Wang1, Jing Fu1, Linhong Song1, Gang Xu1.   

Abstract

OBJECTIVES: This retrospective study was carried out to define the clinical features and prognostic differences in non-cutaneous malignant melanoma (non-CMM) originating from different anatomic sites.
METHODS: Clinical and follow-up data for 71 patients with non-CMM were collected and reviewed.
RESULTS: Of the 71 non-CMM patients, 59 were diagnosed with mucosal malignant melanoma (MMM) and 12 with ocular malignant melanoma (OMM). In the 59 MMM patients, the nasal cavity was the most common anatomic site (n = 31, 43.7% of all non-CMM), followed by the oral cavity (n = 9, 12.7%), the genitourinary tract (n = 9, 12.7%), the anorectum (n = 8, 11.3%), and the gastrointestinal tract (n = 2, 2.8%). In the 12 patients with OMM, anatomic sites included the choroid (n = 8, 11.3% of all non-CMM) and the conjunctiva (n = 4, 5.6%). The survival outcome of patients with OMM was much better than that of patients with MMM (P < 0.001). In MMM patients, anorectal melanoma was associated with a worse survival outcome. Age of ≥ 70 years (P < 0.001) and tumor size of > 2 cm (P = 0.02) were significantly poor prognostic factors in MMM. Age (relative risk [RR] 1.068, 95% confidence interval [CI] 1.006-1.133; P = 0.03) and tumor size (RR 1.410, 95% CI 1.038-1.915; P = 0.028) were independent predictors for the postoperative survival of MMM patients. Patients with these two risk factors had a higher risk for recurrence or death (RR 3.107, 95% CI 1.627-5.595).
CONCLUSIONS: Our findings demonstrate that prognoses differ in patients with different anatomic sites of primary non-CMM. Advanced age and larger tumor size are the main factors affecting prognosis. Patients with poor risk factors should be treated differently to improve their survival outcome.
© 2015 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2015        PMID: 26016703     DOI: 10.1111/ijd.12745

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.

Authors:  Bo Li; Yanru Wang; Yinghui Xu; Hongliang Liu; Wendy Bloomer; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Xin Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-01-17       Impact factor: 7.396

2.  Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.

Authors:  Mengze Hao; Gang Zhao; Xiaoling Du; Yun Yang; Jilong Yang
Journal:  Tumour Biol       Date:  2016-02-04

3.  A first reported case of metastatic anorectal amelanotic melanoma with a marked response to anti-PD-1 antibody nivolumab: A case report.

Authors:  Katsuji Tokuhara; Kazuyoshi Nakatani; Hirotsugu Tanimura; Kazuhiko Yoshioka; Takahiro Kiyohara; Masanori Kon
Journal:  Int J Surg Case Rep       Date:  2017-01-23

4.  Clinical and prognostic factors in 98 patients with malignant melanoma in China.

Authors:  Min Zhang; Nan Zhang
Journal:  J Int Med Res       Date:  2017-06-06       Impact factor: 1.671

5.  Temporal Trends in the Incidence and Mortality of Skin Malignant Melanoma in China from 1990 to 2019.

Authors:  Ruhai Bai; Hui Huang; Minmin Li; Meng Chu
Journal:  J Oncol       Date:  2021-08-24       Impact factor: 4.375

Review 6.  Graphene-Based Electrochemical Sensor for Detection of Hepatocellular Carcinoma Markers.

Authors:  Ying Liang; Yuan Xu; Yaoyao Tong; Yue Chen; Xilu Chen; Shimin Wu
Journal:  Front Chem       Date:  2022-04-08       Impact factor: 5.545

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.